Status:
COMPLETED
Tasso-SST OnDemand Comparator Pilot Study
Lead Sponsor:
Duke University
Conditions:
C3PI Study Testing Group
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Purpose and objective: The purpose of this pilot study is participant user acceptance testing of the Tasso-SST OnDemand device to collect blood for antibody testing. The study will also compare antibo...
Detailed Description
Purpose: The purpose of this pilot study is participant user acceptance testing of the Tasso-SST OnDemand device to collect blood for antibody testing. The study will also compare antibody testing res...
Eligibility Criteria
Inclusion
- Must be a study participant enrolled in the MURDOCK C3PI Study (Pro00105703), participating in the testing cohort of the study.
- Participants are therefore 18 years of age or older, and
- willing to read and complete the consent process.
Exclusion
- No exclusion criteria; however, only up to 100 participants will be enrolled. If more than 100 participants sign consent, some interested participants may not take part in the study.
Key Trial Info
Start Date :
January 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 11 2021
Estimated Enrollment :
135 Patients enrolled
Trial Details
Trial ID
NCT04713748
Start Date
January 15 2021
End Date
March 11 2021
Last Update
July 28 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Duke CTSI Translational Population Health Office
Kannapolis, North Carolina, United States, 28081